Ondansetron Hydrochloride

Spezifikationen

99614-01-4CAS-Nummer

619-448-9EG-Nummer

9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one;hydrochlorideIUPAC-Name

C18H20ClN3OChemische Formel

329.8 g/molMolekulargewicht

ONDANSETRON HYDROCHLORIDE; 99614-01-4; ONDANSETRON HCl; Zophren; Ondemet; ZOFRAN PRESERVATIVE FREE; Ondansetron HCl dihydrate; 2999F27MAD; SN 307; NSC-665799; Zofran and dextrose in plastic container; Ondansetron hydrochloride preservative free; DTXSID701027913; Setofilm; NSC665799; 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-, monohydrochloride; Ondansetron hydrochloride and dextrose in plastic container; ONDANSETRON HYDROCHLORIDE ANHYDROUS; Ondansetron Monohydrochloride; Sumansetron; Demorem; Ondansetron Tablets; RefChem:55780; 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-, monohydrochloride, (+-)-, dihydrate; Sumatriptan succinate, ondansetron; DTXCID701340573; Ondansetron Hydrochloride and Dextrose; 4H-Carbazol-4-one, 1,2,3,9-Tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-, Monohydrochloride, (+-)-; GR 38032F; GR-C507/75; NMH84OZK2B; Odansetron hydrochloride; Ondansetron (as hydrochloride); SN-307; 9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride; MFCD00764297; Ondansetron (Hydrochloride); 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one;hydrochloride; 1,2,3,9-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one hydrochloride; 9-METHYL-3-((2-METHYL-1H-IMIDAZOL-1-YL)METHYL)-2,3-DIHYDRO-1H-CARBAZOL-4(9H)-ONE HYDROCHLORIDE; SMR000469179; ondansetronhydrochloride; Emeset|GR 38032F|NSC 665799|SN 307; NSC 665799; Emetron; Emeset; UNII-2999F27MAD; SR-01000763250; CPD000469179; 9-Methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one monohydrochloride; SCHEMBL41455; MLS001304076; MLS001401397; MLS002222312; REGID_for_CID_68647; orb1227091; orb1300613; orb1300614; Ondansetron hydrochloride, 98%; CHEMBL1201111; SCHEMBL29607040; HMS1571C18; HMS5079D19; HY-B0002; Ondansetron hydrochloride and sodium chloride in plastic container; HB2832; s1390; ONDANSETRON HYDROCHLORIDE [MI]; AKOS015889292; AB07046; CCG-100852; CCG-221058; CS-1715; FO65112; GS-3597; NC00102; AC-12464; BO164177; ONDANSETRON HYDROCHLORIDE [WHO-DD]; O0407; Ondansetron hydrochloride - Bio-X trade mark; SW100810-5; T6615; T6616; VU0424014-2; C90628; (+/-)-ONDANSETRON HYDROCHLORIDE ANHYDROUS; ONDANSETRON HYDROCHLORIDE ANHYDROUS, (+/-)-; SR-01000763250-5; Q27254405; 1,2,3,4-TETRAHYDRO-9-METHYL-3-((2-METHYL-1H-IMIDAZOL-1-YL)METHYL)-9H-CARBAZOL-4-ONE HYDROCHLORIDE; 4H-CARBAZOL-4-ONE, 1,2,3,9-TETRAHYDRO-9-METHYL-3-((2-METHYL-1H-IMIDAZOL-1-YL)METHYL)-, HYDROCHLORIDE (1:1); 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1H-carbazol-4-one hydrochloride; 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one;hydrochloride dihydrateSynonyme